1. From the Institute of Molecular and Translational Therapeutic Strategies, IFB-Tx (J.V., T.T.) and Excellence Cluster REBIRTH (T.T.), Hannover Medical School, Germany; and National Heart and Lung Institute, Imperial College London, United Kingdom (T.T.).